Xingguo Zhu

8PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesChemical thermodynamics and energeticsMolecular imaging (incl. electron microscopy and neutron diffraction)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
L-2-Hydroxyglutarate sensitizes ferroptosis through ATF3/CHAC1-mediated glutathione degradation in hepatocellular carcinoma.

|May 14, 2025
Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation-A Short Review.

Athena Starlard-Davenport, Chithra D Palani, Xingguo Zhu

|Jan 06, 2025
Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice.

Caixia Xi, Junfeng Pang, Weinan Xue

|Mar 28, 2024
Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease.

Caixia Xi, Chithra Palani, Mayuko Takezaki

|Jun 26, 2023
Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA-Mediated Metabolic and Epigenetic Regulatory Networks.

Caixia Xi, Junfeng Pang, Amanda Barrett

|Jun 02, 2023
Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease.

Caixia Xi, Junfeng Pang, Wenbo Zhi

Pageof 2

Frequent Collaborators

3 joint publications

Anatolij Horuzsko

2 joint publications

Huidong Shi

2 joint publications

Betty S Pace

1 joint publications

Wenbo Zhi